STUDY QUESTION: Does bone morphogenetic protein 2 (BMP2) regulate connexin43 (Cx43) and modulate cell-cell communication in luteinized human granulosa cells?
Introduction
In many multi-cellular organisms, intimate cell-cell communication relies on several types of functional cell junction (Loewenstein, 1981) . Among these cell junctions, the gap junction is a cylindrical, channel-like structure that directly connects two adjacent cells and permits the intercellular transportation of various smaller materials, including ions, metabolites, nutrition and second messengers (Caspar et al., 1977) . Connexins (also known as gap junction proteins) are a group of structurally related transmembrane proteins that form a variety of gap junctions (Beyer et al., 1990) . Connexin-coupled gap junctions are presented in most mammalian cells and play important roles in a broad range of normal and pathological events, including the female reproductive system (Pointis et al., 2005; Gershon et al., 2008; Nielsen et al., 2012) . In many species including humans, recent studies have identified several connexin isoforms in the ovarian tissues that play pivotal roles in the modulation of folliculogenesis, oocyte maturation and luteal function (Grazul-Bilska et al., 1996; Ackert et al., 2001; Gershon et al., 2008) .
Connexin 43 (Cx43) (official gene name; gap junction protein alpha 1 (GJA1)) is expressed and localized in the human and baboon corpus luteum (Khan-Dawood et al., 1996) . The expression levels of Cx43 vary throughout the different developmental stages of the corpus luteum, with the highest levels in the mid-luteal phase (the maximally active phase of this tissue). However, Cx43 is undetectable in the corpus albicans (Khan-Dawood et al., 1996) . In the bovine ovary, the highest expression of Cx43 in the corpus luteum is detected during the early luteal phase (Berisha et al., 2009) . In ovine luteal cells, there is a positive correlation between progesterone secretion and Cx43 mRNA expression as well as the gap junction intercellular communication (GJIC) of the luteal cells (Borowczyk et al., 2007) . Collectively, all these studies suggest that Cx43-coupled gap junctions are involved in the cellular mechanisms of the tissue remodeling and steroidogenesis during the corpus luteum development and maintenance.
Bone morphogenetic proteins (BMPs), members of the transforming growth factor beta (TGF-β) superfamily, have been shown to play critical roles in the regulation of mammalian reproduction (Shimasaki et al., 2004) . Some of the BMP subfamily members and their receptors are expressed in the human ovary (Abir et al., 2008; Kristensen et al., 2014; Chang et al., 2016b) . A recent study has reported the increased expression of BMP2, BMP4 and BMP6 in the human corpus luteum, and these BMPs are negatively regulated by the luteotropic hCG (Nio-Kobayashi et al., 2015) . Moreover, in vitro studies have demonstrated that BMPs may possess the opposite effects to hCG and suppress luteinization and progesterone production in the luteinized human granulosa cells (Chang et al., 2013a; Nio-Kobayashi et al., 2015; Zhang et al., 2015) . All of these data has provided the evidence that BMPs are potent mediators of luteolysis during the luteal phase. In bovine and rat ovaries, BMP2 mRNA levels are highly expressed in the regressing follicles (Erickson and Shimasaki, 2003; Fatehi et al., 2005) . Similarly, in sheep ovaries, BMP2 mRNA is only detected in the degenerating granulosa cells of atretic follicles, but not in healthy follicles (Juengel et al., 2006) . In the human corpus luteum, the expression levels of BMP2 mRNA and protein are progressively increased in the late-luteal phase (Nio-Kobayashi et al., 2015) . Given the fact that the spatiotemporal expression of BMP2 in the luteal phase is negatively correlated with the dramatically cyclic expression of Cx43 in the human corpus lutem (Nio-Kobayashi et al., 2015) , we therefore proposed that BMP2 might play a role in the regulation of Cx43 in the luteinized human granulosa cells, which further hampers the intercellular communication and facilitates the process of luteolysis. The aim of this experimental study was to investigate the effect of BMP2 on the expression of Cx43 and the related GJIC activity in the luteinized human granulosa cells as well as the involved underlying mechanisms.
Materials and Methods

Cell culture
A non-tumorigenic immortalized human granulosa cell line, SVOG (previously developed by our laboratory staff, Dr Leung's Lab, Vancouver, Canada), which was previously produced by a Simian virus 40 large T antigen transfection of early luteal phase human granulosa cells obtained from patients undergoing IVF (Lie et al., 1996) , was used in this study. Because the immortalized SVOG cells were generated from primary human granulosa-lutein cells, they display biological responses to many different treatments that are similar to the responses of primary human granulosalutein cells (Chang et al., 2014 (Chang et al., , 2015a (Chang et al., ,b,c, 2016a . The SVOG cells were counted with a hemocytometer, and cell viability was assessed by a 0.04% Trypan blue exclusion. The percentage of viable cells before and after the culture is over 95%. The cells were seeded (2-4 × 10 5 cells/ml in six-well plates) and cultured in DMEM/F-12 medium supplemented with 10% charcoal/ dextran-treated fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin sulfate and 1× GlutaMAX (Gibco, Invitrogen, Carlsbad, CA, USA). Cultures were maintained at 37°C in a humidified atmosphere containing 5% CO 2 and 95% air. Culture medium was changed every other day in all experiments. Before being treated with growth factors, SVOG cells were cultured in serum-free medium for 24 h.
Reagents and supplies
The recombinant human BMP2 (BMP2) (355-BM-010), which was a Chinese hamster ovary cell-derived recombinant protein, was purchased from R&D Systems (Minneapolis, MN, USA ) (#13820) (diluted at 1:1000) (Cell Signaling Technology, Beverly, MA, USA) and anti-SMAD4 (#38454) (diluted at 1:1000) antibodies (Cell Signaling Technology). Secondary antibodies used in this study were: a horseradish peroxidase-conjugated goat anti-rabbit antibody (diluted at 1:5000) (Bio-Rad Laboratories, Hercules, CA, USA) and a goat anti-mouse IgGs (diluted at 1:5000) (Bio-Rad Laboratories).
RT-qPCR
After specific treatment, SVOG cells were first washed with cold PBS before the extraction procedure. TRIzol Reagent (Invitrogen, Life Technologies) was used to extract the total RNA according to the manufacturer's instructions. A total amount of 2 μg RNA was reverse transcribed into the firststrand cDNA using random primers and a specific Reverse Transcriptase enzyme derived from Moloney Murine Leukemia Virus (MMLV) (Promega, Madison, WI, USA). For each qPCR reaction, a total amount of 20 μl containing 1× SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA), 20 ng of cDNA and 250 nM of each specific primer was used to perform the experiments. The primers used in this study were as follows: GJA1 (Cx43), 5′-TAC CAA ACA GCA GCG GAG TT-3′ (sense) and 5′-TGG GCA CCA CTC TTT TGC TT-3′ (antisense) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 5′-ATG GAA ATC CCA TCA CCA TCT T-3′ (sense) and 5′-CGC CCC ACT TGA TTT TGG-3′ (antisense). The 96-well optical reaction plates were used to perform the qPCR using a device of Applied Biosystems 7300 Real-Time PCR System. Dissociation curve analysis and agarose gel electrophoresis of the PCR products were used to validate the specificity of the RT-qPCR assay. In particular, we validated the assay performance by evaluating amplification efficiencies (by means of calibration curves) to ensure that the plot of log input amount vs Cq (also known as CT (cycle threshold)) had a slope <0.1. For the expression of specific receptors, the TaqMan gene expression assays specific for ALK2 (ACVR1), ALK3 (BMPR1A), ALK6 (BMPR1B) and GAPDH (Hs00153836_m1, Hs01034913_g1, Hs00176144_m1 and Hs02758991_g1, respectively; Applied Biosystems) were performed in triplicate on corresponding cDNA samples. For each TaqMan reaction, a total amount of 20 μl containing 4 μl of cDNA, 5 μl of RNase-free water, 10 μl of 2× TaqMan gene expression master mix (Applied Biosystems) and 1 μl of 20× TaqMan gene expression assay was used. At least three separate experiments were performed on different cultures, and each sample was assayed in triplicate. A mean value was generated from each assay for the determination of mRNA levels using the comparative Cq (2 -ΔΔCq ) method. GAPDH was used as the reference (internal control) gene.
Western blot analysis
After specific treatment, cells were washed with PBS and lysed in a lysis buffer (20 mM Tris, 150 mM NaCl, 1 mM Na 2 EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na 3 VO 4 , 1 μM aprotinin, 1 μM leupeptin and 1 mM PMSF) (Cell Signaling Technology) containing a protease inhibitor cocktail (Sigma-Aldrich).
Extracts were centrifuged at 14 000 rpm for 15 min at 4°C to remove cellular debris. Protein concentrations were quantified using a DC Protein Assay (Bio-Rad Laboratories). Equal amounts (a total of 50 μg) of protein were separated via 10% SDS-PAGE and transferred onto polyvinylidene fluoride membranes. Then we blocked the membranes with 5% nonfat dry milk in Tris-buffered saline containing 0.05% Tween 20 for 1 h and incubated overnight at 4°C with specific primary antibodies. After washing with 1× Tris-buffered saline, the membranes were incubated with the appropriate horseradish peroxidase-conjugated secondary antibody for 1 hour. Finally, the immunoreactive bands were detected using an enhanced chemiluminescent substrate or a SuperSignal West Femto Chemiluminescence Substrate (Pierce, Rockford, IL, USA). As needed, the membranes were stripped with stripping buffer that contained 50 mM Tris-HCL (pH = 7.6), 10 mmol/l β-mercaptoethanol and 1% SDS at 50°C for 30 min and re-probed using rabbit anti-SMAD1/5/8 or mouse anti-α tubulin antibody as a loading control. The Scion imaging software (Scion Corp., Frederick, MD, USA) was used to quantify the image densitometry of the scanned films.
siRNA transfection
The transient knockdown assays were performed with an ON-TARGETplus Non-targeting Control Pool or separate ON-TARGETplus SMART pools targeting ALK2 (ACVR1), ALK3 (BMPR1A), ALK6 (BMPR1B) or SMAD4 (Thermo Fisher Scientific). Before the transfection, the cells were precultured until reaching 50% of cell confluence in antibiotic-free DMEM/F12 medium (with 10% charcoal/dextran-treated fetal bovine serum). Then the cells were transfected with 25 nM siRNA using Lipofectamine RNAiMAX (Life Technologies) for 48 h. RT-qPCR or Western blot analysis were used to verify the knockdown efficiency for each target.
Scrape loading and dye transfer assay
A scrape loading and dye transfer assay was used to evaluate the effects of BMP2 on GJIC between the SVOG cells. This assay is based on monitoring the transfer of the fluorescent dye Lucifer yellow (MW 457.2) from one cell into the neighboring cell via the functional gap junctions. This technique has been used to introduce macromolecular substances into cultured cells effectively by producing a transient tear in the cell membrane,based on the fact that Lucifer yellow cannot diffuse through intact cell membranes; however, its low molecular weight allows it to transfer to neighboring cells through intact gap junctions. After specific treatment, fully confluent cells were washed with PBS and scraped using a surgical blade before the addition of fluorescent dye (0.5% Lucifer yellow CH, potassium salt, Life Technology). After 5 min of incubation, the cells were washed, fixed with 4% paraformaldehyde and finally imaged with a Zeiss Axiophot fluorescence microscope (equipped with a digital camera). GJIC were evaluated by measuring the distance from the scrape line to the furthest extent of the dye-coupled cells.
Statistical analysis
The results were analyzed by one-way ANOVA followed by Tukey's multiple comparisons test using PRISM software (GraphPad Software, Inc., San Diego, CA, USA). The results are presented as the mean ± SEM of at least three independent experiments. Data were considered significantly different from each other if P < 0.05.
Results
BMP2 down-regulates Cx43 expression in SVOG cells
First of all, We investigated whether BMP2 modulates the expression of Cx43 in luteinized human granulosa cells. The SVOG cells were treated with vehicle control or addition of recombinant human BMP2 (BMP2) (concentration from 1, 10 to 100 ng/ml), based on the fact that the concentrations of BMP2 in follicle fluid of IVF patients range from 1 to 110 ng/ml (Sugiyama et al., 2010) . The concentration-dependent study showed that the treatment with BMP2 for 12 h significantly decreased the levels of Cx43 mRNA (Fig. 1A ) and Cx43 protein (Fig. 1B) in a concentration-dependent manner (Fig. 1) . Furthermore, the time course study showed that the suppressive effects of BMP2 (30 ng/ml) (chosen as it represents the average concentration of BMP2 in follicle fluid which is 25-35 ng/ml) (Sugiyama et al., 2010) on Cx43 mRNA were detected at all the time points (3, 6, 12 and 24 h) examined (Fig. 1C) . Likewise, the suppressive effects of BMP2 (30 ng/ml) on Cx43 protein levels were detected at 6, 12 and 24 h after treatment (Fig. 1D ).
BMP2 increases the phosphorylated SMAD1/5/8 protein in SVOG cells
Next, we sought to investigate the underlying mechanism by which BMP2 down-regulated the Cx43 expression. The Western blot analysis was used to examine the levels of phosphorylated and total SMAD1/5/8 proteins after cell exposure to BMP2. The time course study showed that treatment of SVOG cells with 30 ng/ml of BMP2 for 30, 45 or 60 min profoundly increased the phosphorylated SMAD1/5/8 proteins ( Fig. 2A) . for 12 h, and Cx43 mRNA levels were examined using RT-qPCR (with GAPDH as a reference gene for normalization). (B) Cells were treated with different concentrations (1, 10 or 100 ng/ml) of BMP2 for 24 h, and Cx43 protein levels were examined using Western blot analysis (quantified data are normalized to α-tubulin). (C) Cells were treated with 30 ng/ml of BMP2 for 3, 6, 12 or 24 h and Cx43 mRNA levels were examined using RT-qPCR.
(D) Cells were treated with 30 ng/ml of BMP2 for 3, 6, 12 or 24 h, and Cx43 protein levels were examined using Western blot analysis (quantified data are normalized to α-tubulin). The results are expressed as the mean ± SEM of at least three independent experiments. Values marked with different letters are significantly different (P < 0.05). B2, BMP2; Ctrl, control; Cx43, connexin43.
receptors) (Wrana et al., 1992) , of which type I receptor is the principle determinants of signal specificity and the downstream receptorregulated SMAD phosphorylation (Miyazono et al., 2001) . In different cell types, three BMP type I receptors (ALK2, ALK3 and ALK6) have been reported to mediate the cellular action of BMPs (Miyazono et al., 2001) . To investigate the involvement of BMP type I receptors in the BMP2-induced phosphorylation of SMAD1/5/8 and down-regulation of Cx43, we then used a pharmacological inhibition approach. Dorsomorphin is a specific receptor kinase inhibitor of ALK2/ALK3/ ALK6 and DMH-1 is a selective inhibitor of ALK2/ALK3, whereas SB431542 is a potent inhibitor of ALK4/ALK5/ALK7 (Inman et al., 2002; Yu et al., 2008; Hao et al., 2010) . The results showed that pretreatment with either Dorsomorphin or DMH-1 abolished BMP2-induced increases in SMAD1/5/8 phosphorylation ( Fig. 2B ) and down-regulation of Cx43 expression (Fig. 3) . That is, complete blockage of the function of ALK2 and ALK3 by DMH-1 could inhibit the downstream effect induced by BMP2. These findings suggest that ALK2 and/or ALK3, but not ALK6, are required for the activation of SMAD1/5/8 and down-regulation of Cx43 in SVOG cells. To further exclude the involvement of other TGF-β type I receptors in the BMP2-induced signaling and action, we pre-treated the cells with SB431542 (inhibitor of ALK4/5/7), and the results showed that SB431542 did not alter the BMP2-induced phosphorylation of SMAD1/5/8 ( Figure 2B ) and down-regulation of Cx43 expression (Fig. 3 ).
ALK2 and ALK3 are required for the BMP2-induced phosphorylation of SMAD1/5/8 and down-regulation of Cx43 in SVOG cells
To further investigate which ALKs mediate the BMP2-induced SMAD1/5/8 phosphorylation, we used a target depletion approach (specific siRNAs) to knockdown the endogenous ALK2, ALK3 or ALK6 in SVOG cells. The RT-qPCR was used to confirm the knockdown efficiency, and the results showed that transfection with siRNA targeting ALK2, ALK3 or ALK6 significantly decreased the mRNA (30 ng/ml) for 30, 45 or 60 min and levels of phosphorylated SMAD1/ 5/8 were examined using Western blot analysis (quantified data are normalized to total SMAD1/5/8). (B) Cells were treated with BMP2 (30 ng/ml) for 60 min in DMSO (as the vehicle control) or in DM (10 μM), DMH-1 (10 μM) or SB431542 (10 μM), and the phosphorylated SMAD1/5/8 protein levels were examined using Western blot analysis (quantified data are normalized to total SMAD1/5/8). The results are expressed as the mean ± SEM of at least three independent experiments. Values marked with different letters are significantly different (P < 0.05). B2, BMP2; Ctrl, control; DM, Dorsomorphin.
Figure 3 Effects of BMP/TGF-β type I receptor inhibitors (DM,
DMH-1 and SB431542) on the BMP2-induced down-regulation of Cx43 protein expression in SVOG cells. Cells were treated with BMP2 (30 ng/ml) for 24 h in DMSO (as the vehicle control) or in DM (10 μM), DMH-1 (10 μM) or SB431542 (10 μM), and the Cx43 protein levels were examined using Western blot analysis (quantified data are normalized to α-tubulin). The results are expressed as the mean ± SEM of at least three independent experiments. Values marked with different letters are significantly different (P < 0.05). B2, BMP2; Ctrl, control; Cx43, connexin 43; DM, Dorsomorphin. levels of only the targeted ALK (Fig. 4A) . Interestingly, individual knockdown of either ALK2 or ALK3 attenuated, but not completely abolished the BMP2-induced SMAD1/5/8 phosphorylation, whereas the down-regulation of ALK6 had no effect (Fig. 4B) . However, concomitant knockdown of ALK2 and ALK3 (combined siALK2 and siALK3) further significantly attenuated the BMP2-induced SMAD1/5/8 phosphorylation (Fig. 4C) . Consistent with these findings, individual knockdown of either ALK2 or ALK3 partially reversed the BMP2-induced down-regulation of Cx43 expression (Fig. 4D) , and the simultaneous knockdown of ALK2 and ALK3 totally reversed the suppressive effect of BMP2 on Cx43 expression (Fig. 4E) . These results indicate that both ALK2 and ALK3 are required for the phosphorylation of SMAD1/5/8 as well as for the down-regulation of Cx43 expression that occurs in response to BMP2 in luteinized human granulosa cells.
SMAD1/5/8-SMAD4 signaling is required for the BMP2-induced down-regulation of Cx43 expression in SVOG cells
In the canonical SMAD-dependent signaling pathway, activated and phosphorylated SMAD1/5/8 must associate with a common SMAD (Co-SMAD) SMAD4, and translocate into the cell nucleus to regulate the downstream target gene expression (Zhang et al., 1996) . To examine whether SMAD1/5/8 signaling is required for the BMP2-induced down-regulation of Cx43, siRNA target SMAD4 was used to knock down the endogenous SMAD4. The Western blot analysis showed that after transfection of the cells for 24 and 48 h, SMAD4 siRNA significantly decreased the SMAD4 protein levels relative to the control siRNA (Fig. 5A) . Notably, transfection of the cells with SMAD4 siRNA for 48 h completely abolished the suppressive effect of BMP2 on Cx43 expression (Fig. 5B) . These results indicate that SMAD1/5/8-SMAD4 signaling is required for the BMP2-induced down-regulation of Cx43 expression in SVOG cells.
BMP2 decreases GJIC cells in SVOG cells
To further investigate whether the BMP2-induced down-regulation of Cx43 correlated to the decrease in GJIC activity between SVOG cells, we used a scrape loading and dye transfer technique. As shown in Figure 6 , treatment of the cells with 30 ng/ml of BMP2 for 24 h significantly reduced the number of Lucifer yellow fluorescent dye-coupled cells on either side of the scrape. Additionally, pre-treatment with 10 μM of Dorsomorphin inhibitor reversed the BMP2-induced decrease in GJIC activity (Fig. 6) . These results indicate that BMP2 indeed reduces the cell-cell communication in SVOG cells.
Discussion
After ovulation, the cellular components that reside in the ruptured follicle form a temporary endocrine structure called the corpus luteum, which produces a significant amount of progesterone. Emerging evidence indicates that cell-cell communication between the luteal cells through contact-dependent interaction enhances the synthesis and secretion of progesterone (Redmer et al., 1991; Khan-Dawood et al., 1998) . In addition to the steroidogenic cells, the bovine corpus luteum consists of a heterogeneous population of nonsteroidogenic cells, most of which are endothelial cells (Pate, 1996) . Endothelial cells express the neural cell adhesion molecule that mediates the cell adhesion and contributes to the functional interaction between endothelial and luteal cells (Mayerhofer et al., 1992) . Furthermore, endothelial cellderived endothelin-1 may inhibit the synthesis of progesterone and prostaglandin I2 by luteal cells (Milvae et al., 1996) . Cx43-coupled gap junctions are localized in the luteal cells of both human and baboon corpus luteums throughout the luteal developmental stages, but are not detectable in the corpus albicans (Khan-Dawood et al., 1996) . Gap junctions are also present in nonsteroidogenic cells of luteal tissue in several species that play pivotal roles in luteal hormone production, signal transduction, angiogenesis and luteolysis (Grazul-Bilska et al., 1997) . This gap junction intercellular interaction is tightly modulated by some systemic and local regulators of luteal function in a stage-dependent manner (Grazul-Bilska et al., 1997). Indeed, several luteotropic factors, such as hCG and oxytocin have been shown to increase the progesterone synthesis by up-regulating the expression of Cx43 (Khan-Dawood et al., 1998) . In the present study, we demonstrate, for the first time, that BMP2 down-regulates Cx43 mRNA and protein expression, which may contribute to the decrease in gap junction-mediated intercellular communication in luteinized human granulosa cells. Previous studies have shown that the expression of BMP2 is increased in the regressing human corpus luteum, and the expression can be suppressed by the addition of hCG (a potent luteotropic factor) in both in vivo and in vitro systems (Nio-Kobayashi et al., 2015) . Furthermore, in vitro studies have shown that BMP2 has an opposite effect to hCG in regulating the human luteal functions. Specifically, treatment of BMP2 suppresses the expression of luteinizing hormone/choriogonadotropin receptor and steroidogenic acute regulatory protein, two components essential for progesterone production (Yu et al., 2008) . All of these studies reinforce the notion that BMP2 is a potent luteolytic mediator in the human corpus luteum. Our findings suggest a novel cellular mechanism by which luteinized granulosa cells can interact with neighboring cells to suppress the formation of the Cx43-coupled gap junctions needed for the luteal regression. Such a mechanism provides a regulatory feedback control over locally produced cell junctions, which is essential for tissue remodeling and recovery if fertilization does not occur. Consistent with the present study, our recent studies have demonstrated that oocyte-and theca cell-derived BMPs (BMP15, BMP4 and BMP7) may exert similar paracrine effects to regulate Cx43 expression and GJIC activity in human granulosa-lutein cells (Chang et al., 2013b (Chang et al., , 2014 . In this regard, BMPs may have dual functions in the menstrual cycle, as BMPs prevent premature luteinization during the follicle phase, while promoting luteolysis during the luteal phase.
In contrast to our results, BMP2-induced chondrogenic differentiation by increasing Cx43 expression and gap junction-mediated intercellular communication in chicken undifferentiated mesenchymal cells (Zhang et al., 2002) . In mouse osteoblast cells, BMP2 positively modulated GJA1 (Cx43) promoter activity (Chatterjee et al., 2003) . This discrepancy could be resulted from the interspecies differences or because of the fact that the molecular mechanisms underlying the BMP2-driven target gene regulation are cell type-dependent (Massague, 2012) . Our most recent studies showed that another TGF-β superfamily member TGF-β1 could increase GJIC activity by up-regulating Cx43 expression in luteinized human granulosa cells (Chen et al., 2015) , indicating competing roles for these intra-follicular growth factors. The differential downstream signaling of these two growth factors (TGF-β1 vs BMP2) may explain the opposite cellular function seen in the same cell model. In particular, SMAD2/3 mediate the TGF-β1-induced cellular action, whereas SMAD1/5/8 mediate the BMP2-induced cellular response (Moustakas, 2002) . The results of our study showed that BMP2 down-regulated the expression of Cx43 through a SMAD1/5/8-SMAD4-dependent manner, indicating that the human Cx43 promoter has at least two transcriptional response elements, which could be targeted by two different subsets of SMAD complexes and modulated in an opposite manner. Notably, two different SMAD binding elements have been reported in the human and mouse Cx43 promoters (Chatterjee et al., 2003) . Nonetheless, this study did not demonstrate a role of BMP2 in the modulation of other connexin isoform expression and the related GJIC activity in luteinized human granulosa cells. To date, the knowledge of the regulatory control of the expression of any connexin isoform other than Cx43 is limited. Future research aimed at addressing this question is warranted.
A comprehensive understanding of the molecular mechanisms underlying the BMP2-induced cellular response will be beneficial to the development of pharmacological strategies for clinical application. Although, three BMP type I, ALK2, ALK3 and ALK6 have been implicated in the BMP-induced SMAD1/5/8 phosphorylation, the specific receptors responsible for mediating the biological effects of BMP2 in human luteal cells remain poorly defined (Mueller and Nickel, 2012) . The current study used three BMP/ TGF-β type I receptor inhibitors to investigate the required receptors responsible for the BMP2-induced biological effects in SVOG cells. Our results showed that pre-treatment with ALK2/3/6 inhibitor Dorsomorphin or ALK2/3 inhibitor DMH-1 (but not ALK4/5/7 inhibitor SB431542) abolished the effects of BMP2 on SMAD1/5/8 phosphorylation and Cx43 expression, indicating that ALK4/5/6/7 are not the corresponding receptors. Considering the off target effects of these kinase inhibitors, we chose another inhibition approach using specific siRNAs to further define which ALKs mediate the cellular response of BMP2. The results from target depletion experiments showed that dual knockdown of ALK2/ALK3 reversed the effects of BMP2 on SMAD1/5/8 phosphorylation and Cx43 expression, indicating that ALK2 and ALK3 are required for the BMP2 signaling and action. We have previously demonstrated the differential subsets of BMP type I receptor required for BMP4 and BMP7 signaling in SVOG cells: ALK3 and/or ALK6 for BMP4, whereas ALK2 and/or ALK3 for BMP7 (Chang et al., 2015a) . In this context, sequence and structure differences in BMPs most likely account for their differing binding affinity to the BMP type I receptors. In spite of the fact that BMP2/4 subgroup share over 90% amino acid sequence identity, but are only 60% identical to members of the BMP5/6/7/8 subgroup (Letsou et al., 1995; Solloway and Robertson, 1999; Zhao, 2003) , BMP2 acts in a similar manner to regulate Cx43 expression as BMP7 does (to regulate pentraxin 3) in SVOG cells. These unexpected findings suggest that luteinized human granulosa cells could have the capacity to signal and regulate different target genes through differential subsets of type I receptor in response to various BMPs. Future studies aimed at identifying the putative differential subsets of BMP type I receptor in response to particular cellular action and the underlying mechanisms will be of great interest, because the related research could help design novel pharmaceutical therapy.
The BMP2 mRNA is highly expressed in the human corpus luteum, with the highest expression during the late-luteal phase (NioKobayashi et al., 2015) . We showed in this study that BMP-stimulated cell signaling (i.e. SMAD1/5/8) was present in these cells. The current study further demonstrated that BMP2 is able to act on luteinized granulosa cells in a paracrine/autocrine manner, which could be extended to the neighboring endothelial cells through functional gap junctions. Cx43-coupled gap junctions have been shown to regulate cell proliferation and cell viability in many cell types of various species (Gramsch et al., 2001; Qiu et al., 2016) . In this regards, luteal cellderived BMP2 may modulate luteal function through down-regulating Cx43 expression and modulating cell proliferation during the lateluteal phase. However, the limitation of this study is that data generated from the experiments were based on an immortalized human granulosa-lutein cell line, SVOG cells. These cells have been exposed to high pharmaceutical doses of gonadotrophins (FSH or LH) and human chorionic gonadotrophin stimulation. Another limitation of this study is that single cell paradigm of the cell model was used to investigate the cell-cell communication. Therefore, the expression patterns of growth factors, receptors and signaling transduction mediators could be different from those in the in vivo system. Future studies focused on a three-dimensional cell culture system that includes multiple cells (large luteal, small luteal and endothelial cells) will provide more information regarding the normal luteal function.
In summary, we have shown that BMP2 down-regulates the expression of Cx43 expression and decreases the intercellular communication in luteinized human granulosa cells. Moreover, our results indicate that the suppressive effects of BMP2 are likely mediated via the ALK2 and ALK3 BMP type I receptors and most likely involve a SMADdependent signaling pathway. These findings shed light on the potential functional role of BMP2 in the process of luteolysis during the late luteal phase.
